Log off SitemapDisclaimer

Hypoventilation pain can be relieved with Matrifen®

Hypoventilation can be painfull - Matrifen® from Nycomed relieves the pain and has fewer adverse effects than other similar products.

Matrifen® eases the pain of hypoventilationMatrifen®  helps to relieve the pain of hypoventilation and other chronic pain.

>> More information on hypoventilation and Matrifen®

Matrifen® is a transdermal fentanyl patch indicated for patients with hypoventilation and severe chronic pain such as cancer pain and other chronic distressing pain.

It is beneficial for patients with respiratory depression, hypoventilation, cognitive impairment, peripheral diabetic neuropathy, osteoarthritis, rheumatoid arthritis and cancer pain and is approximately 50 to 100 times as potent as morphine.

About Nycomed
Nycomed is driving a new way of providing pharmaceutical products in Europe. Physicians are seeking new treatments that make a clear medical difference. But traditional pharmaceutical companies, with a single research department, are finding it harder to meet this need.

Nycomed, by contrast, can access the work of thousands of companies dedicated to research, and choose to make available the most innovative treatments.

Special features

To access the site you must confirm being a healthcare professional - use the link on the left side of this page

Mode of action video

An animation presenting the Matrifen® patch;
- Application
- Mode of action

Additional material

- Product details
- Pharmacokinetics
- Technical profile
Conversion tables for download 

- Oral morphine to Matrifen (100:1)
- Oral morphine to Matrifen (150:1)
- Potency table